हिंदी में पढ़ें

Pfizer Inc

Setback for Pfizer, US FDA issues warning letter to company's Vizag plant

Setback for Pfizer, US FDA issues warning letter to company's Vizag plant

Wed, Apr 01, 2020

Pharmaceutical major Pfizer has been issued a warning letter by US FDA on issues of failed sterility test, Environmental Monitoring Program and data integrity remediation issues; Warning letter was issued on 25 March, against the Vishakhapattanam plant of the company

Pfizer Inc to split company into three units

Pfizer Inc to split company into three units

Wed, Jul 11, 2018

U.S. drugmaker Pfizer Inc said on Wednesday it would split its business into three units and one of them would include a new hospital business segment. The three new units are innovative medicines, established medicines and consumer healthcare.

Pfizer Inc to split company into three units

Pfizer Inc to split company into three units

Wed, Jul 11, 2018

U.S. drugmaker Pfizer Inc said on Wednesday it would split its business into three units and one of them would include a new hospital business segment. The three new units are innovative medicines, established medicines and consumer healthcare.

TRENDING NOW

Pfizer Inc recalls 1.80 million vials of anti-biotics

Pfizer Inc recalls 1.80 million vials of anti-biotics

Wed, May 23, 2018

Pfizer Inc has recalled over 1.80 million vials of piperacillin and tazobactam, that were manufactured in India, from the USA market. According to a notification of the US Food and Drug Administration, the product was manufactured by Hospira Healthcare India Private Limited, a Pfizer company, at its plant at Irungattukottai near Chennai for Apotex Corpto be sold in the USA.

Pfizer ends research for new Alzheimer''s, Parkinson's drugs

Pfizer ends research for new Alzheimer''s, Parkinson's drugs

Mon, Jan 08, 2018

Pfizer is not making any changes to research and development funding for tanezumab, which is marketed as a treatment for joint pain from osteoarthritis, fibromyalgia treatment Lyrica, or its rare disease program.

US drugmaker Pfizer abandons plan to split into two companies; stock falls nearly 2%

US drugmaker Pfizer abandons plan to split into two companies; stock falls nearly 2%

Mon, Sep 26, 2016

US drugmaker Pfizer Inc, which has been considering a split into two companies for more than two years, said on Monday it would not do so because the move would not create any shareholder value.

Load More

LIVE TV

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x